Anavex Life Sciences

Type: Company

Name: Anavex Life Sciences

First reported May 14 2013 - Updated May 14 2013 - 1 reports

ARCA Biopharma has the Lowest Sales per Share in the Biotechnology Industry (ABIO, AMRN, ANX, AVXL, CHTP)

Below are the three companies in the Biotechnology industry with the lowest sales per share. Sales per share is a valuable metric in comparing relative value for companies in the same industry.ARCA Biopharma ranks lowest with a sales per share of $0.00. ... [Published Comtex SmarTrend - May 14 2013]

Entities: ARCA Biopharma Inc, Chelsea Therapeutics International, Biotechnology

First reported May 06 2013 - Updated May 07 2013 - 3 reports

Anavex Life Sciences Corp to submit a funding application for Phase 2a trial of ANAVEX 2-73 in Alzheimer's patients

Pharmaceutical company Anavex Life Sciences Corp (OTC Markets:AVXL) revealed on Monday that it has been invited to submit a full grant application to the Alzheimer's Drug Discovery Foundation (ADDF) for a Phase 2a trial of ANAVEX 2-73.The company said ... [Published Individual.com - May 07 2013]

Entities: Anavex Life Sciences, Alzheimer's Disease, Patient

First reported May 06 2013 - Updated May 06 2013 - 1 reports

Fully Automated Diagnostic Device Receives CE Certification; IDx LLC Planning For Rollout Across Europe

/PRNewswire/ -- IDx LLC, a company focused on deploying cutting-edge technology to make medical diagnostics more effective, announced earlier today that its first commercial product, IDx-DR, has received CE approval as a Class IIa medical device. CE marking ... [Published NewsBlaze - May 06 2013]

Entities: Certification, Diagnostic, Anavex Life Sciences, Medical Devices, Diabetic Retinopathy

First reported May 06 2013 - Updated May 06 2013 - 1 reports

Feeding America

OrthoAccel® Technologies introduces new AcceleDent Aura® to U.S. and Canadian markets

/PRNewswire/ -- Continuing to follow a remarkable path of innovation and growth, OrthoAccel® Technologies has announced the availability of their newest product, AcceleDent Aura, to orthodontic practices throughout the United States and Canada.AcceleDent ... [Published NewsBlaze - May 06 2013]

Entities: Anavex Life Sciences, United States, Drug Discovery, Feeding America, Patient

First reported May 06 2013 - Updated May 06 2013 - 1 reports

Data Shows that Private Exchange Customers Overwhelmingly Select Different Levels of Benefits Than What Their Employers

/PRNewswire/ -- New data from employees using Bloom Health's defined contribution private exchange shows how more choice and personalization through private exchanges results in many employees selecting benefit packages that are better aligned with their ... [Published NewsBlaze - May 06 2013]

Entities: Anavex Life Sciences, Drug Discovery, Alzheimer's Disease, Medical Devices

First reported Mar 12 2013 - Updated Mar 12 2013 - 1 reports

ANAVEX 2-73 restores mitochondrial functionality, blocks cell death and oxidative stress, preventing PR Newswire

New data presented at International Conference on Alzheimer's and Parkinson's DiseasesVANCOUVER, March 12, 2013 /PRNewswire/ - Anavex Life Sciences Corp. ("Anavex") (AVXL) today announced more promising new data for ANAVEX 2-73, the company's lead drug ... [Published Yahoo! Finance - Mar 12 2013]

Entities: Anavex Life Sciences, Alzheimer's Disease, oxidative stress

Quotes

The company said that the invitation to submit a full application was received following the filing of a Letter of Intent for a grant titled, "Clinical phase 2a study of ANAVEX 2-73 in patients using FDG-PET imaging as a functional biomarker" . It intends to file a full application with the ADDF

Anavex Life Sciences Corp to submit a funding application for Phase 2a trial of ANAVEX 2-73 in Al ... [Published Individual.com - May 07 2013]

"We are excited by this invitation to submit a funding application for a Phase 2a trial of ANAVEX 2-73," said Tom Skarpelos , director of Anavex. "The data generated for ANAVEX 2-73 to date indicates that it has the potential to prevent, halt and/or reverse the course of Alzheimer's disease, which could improve the lives of millions of Americans."

Anavex invited to submit funding application for Phase 2a trial of ANAVEX 2-73 [Published News-Medical.Net - May 07 2013]

"We are thrilled to present AcceleDent Aura," reports OrthoAccel CEO, Mike Lowe. "AcceleDent has accelerated orthodontic treatment worldwide since 2009, and our newest product, AcceleDent Aura, brings the latest in innovative technology to the forefront. A new convenient USB connection makes charging the device simple, as well as providing access to the FastTrac patient usage report via a computer connection."

OrthoAccel® Technologies introduces new AcceleDent Aura® to U.S. and Canadian markets [Published NewsBlaze - May 06 2013]

"This is a game-changer," said IDx CEO, Gary Seamans. "CE IIa certification allows us to market a first-of-its-kind 'doc in a box' that heralds a new era for medicine."

Fully Automated Diagnostic Device Receives CE Certification; IDx LLC Planning For Rollout Across ... [Published NewsBlaze - May 06 2013]

More Content

sort by: Date \| Relevance
Anavex Life Sciences Corp. (AVXL) - Pharmaceuti... [Published TransWorldNews - 14 hours ago]
ARCA Biopharma has the Lowest Sales per Share i... [Published Comtex SmarTrend - May 14 2013]
Anavex Life Sciences Corp to submit a funding a... [Published Individual.com - May 07 2013]
Anavex invited to submit funding application fo... [Published News-Medical.Net - May 07 2013]
CytRx Receives Recommendation for Aldoxorubicin... [Published BioMedReports - May 07 2013]
OrthoAccel® Technologies introduces new AcceleD... [Published NewsBlaze - May 06 2013]
Fully Automated Diagnostic Device Receives CE C... [Published NewsBlaze - May 06 2013]
Anavex invited to file funding application for ... [Published NewsBlaze - May 06 2013]
Data Shows that Private Exchange Customers Over... [Published NewsBlaze - May 06 2013]
EMR Market Grew 15% in 2012: 2013 Electronic Me... [Published NewsBlaze - May 06 2013]
Anavex invited to file funding application for ... [Published Financial Services - May 06 2013]
Anavex comments on FDA plan to expedite approva... [Published PR Newswire: Financial Services - Mar 18 2013]
Anavex Life announces promising data from its l... [Published PharmaBiz - Mar 14 2013]
ANAVEX 2-73 restores mitochondrial functionalit... [Published Yahoo! Finance - Mar 12 2013]
ANAVEX 2-73 restores mitochondrial functionalit... [Published PR Newswire: Financial Services - Mar 12 2013]
Anavex retains Novak Druce Connolly Bove & Quig... [Published PR Newswire: Financial Services - Feb 04 2013]
Anavex appoints Tom Skarpelos as Director [Published PR Newswire: Financial Services - Jan 10 2013]
8-K - ANAVEX LIFE SCIENCES CORP. (0001314052) (... [Published SEC Filings - Jan 10 2013]
Anavex Life releases data from ANAVEX 2-73 cand... [Published PharmaBiz - Oct 22 2012]